Hedge Fund Citadel Hiked Pay, Made Partners as Profits Surged (eFinancialCareers)
Much like Balyasny Asset Management, Citadel appears to have had a favourable year in 2020. The hedge fund has just released accounts for its UK entities in the 12 months to December, and they’re looking good. At Citadel Europe LLP, the partnership which contains Citadel’s highest paid UK people (mostly its portfolio managers), profits available for distribution between the partners went from $770m in 2019 to $999m in 2020. As a measure of Citadel’s success, it’s worth remembering that in 2018, profits at Citadel Europe were ‘just’ $370m.
Inside Two Sigma’s Cloud Strategy: Hundreds of New Engineers, a Multi-Provider Approach, and ‘Tremendous Savings’ (Business Insider)
Two Sigma had a big problem in 2014: the compute power needed for the quantitative fund’s research workflows was 10 times greater than what its data centers could provide. “We said, ‘You know what, we’re not going to build out a 10x physical presence. That’s just enormous, that feels wrong to us,” Camille Fournier, Two Sigma’s head of platform engineering, told Insider.
New York Mets Embark on Branding Effort to Build Cred and Win Young Fans (The Wall Street Journal)
It was a hot Tuesday evening in August, and thousands of loyal New York Mets fans poured into Citi Field to watch their team take on the highly ranked San Francisco Giants. The stadium in Queens brimmed with hope, despite the team’s recent losing streak. The Mets lost that night, 8-zip. “It’s a fixer-upper, for sure,” the new Mets owner, Steven Cohen, said in an interview toward the end of the game. Mr. Cohen, chairman and chief executive officer of hedge fund Point72 Asset Management LP and lifelong Mets fan, bought the team last year in a deal valued at some $2.4 billion. He has set out to log more wins, not only on the scoreboard, but in the hearts and minds of casual and prospective fans.
Tuesday 9/28 Insider Buying Report: AMRK, HIBB (Nasdaq.com)
On Friday, A-Mark Precious Metals’ Director, Kendall Saville, made a $281,706 purchase of AMRK, buying 4,857 shares at a cost of $58.00 a piece. Investors have the opportunity to buy AMRK at a price even lower than Saville did, with shares changing hands as low as $56.73 at last check today — that’s 2.2% under Saville’s purchase price. A-Mark Precious Metals is trading down about 1.4% on the day Tuesday. This buy marks the first one filed by Saville in the past twelve months. And also on Friday, SVP General Counsel David Mitchell Benck purchased $148,676 worth of Hibbett, purchasing 2,000 shares at a cost of $74.34 each. Before this latest buy, Benck made one other buy in the past twelve months, purchasing $175,540 shares for a cost of $87.77 each. Hibbett is trading down about 0.4% on the day Tuesday. So far Benck is in the green, up about 5.7% on their purchase based on today’s trading high of $78.59.
What Did This CEO Just Do with Personal Shares of Marriott International (NASDAQ: MAR)? (Analyst Ratings)
Today, the CEO of Marriott International (MAR), Anthony Capuano, sold shares of MAR for $2.41M. Following Anthony Capuano’s last MAR Sell transaction on April 01, 2019, the stock climbed by 27.0%. In addition to Anthony Capuano, one other MAR executive reported Sell trades in the last month. Based on Marriott International’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $3.15 billion and quarterly net profit of $422 million.
Notable Acceleron Pharma Insider Trades $1.08 Million In Company Stock (Benzinga)
Sujay Kango, EVP And Chief Commercial Officer at Acceleron Pharma (NASDAQ:XLRN), made a large buy and sell of company shares on September 27, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Sujay Kango exercised options to purchase 5,000 Acceleron Pharma shares at a price of $40.61 per share for a total of $203,050 on September 27. They then sold their shares on the same day in the open market. They sold at a price of $175.00 to raise a total of $875,000 from the stock sale.
